Skip to main content
    O

    OPTIMIZERx Corp (OPRX)

    Official site

    HEALTHCARE • HEALTH INFORMATION SERVICES • NASDAQ

    $6.94
    +0.30 (+4.52%)

    Market Cap: $125.07M

    Last updated: Nov 17, 2026 at 4:41 PM ET

    OPTIMIZERx Corp (OPRX) Statistics

    Updated Nov 17, 2026. Figures from company filings and market prices; estimates from consensus analysts.

    OPTIMIZERx (OPRX) has a market cap of $125.07M and an enterprise value of $115.47M. Its trailing P/E of 7.5x is below its 5-year median of 38.6x. Revenue fell 13.98% over the last 12 months from the 12 months before.

    Total Valuation

    Enterprise value is 7.67% below the market cap, as cash exceeds debt.

    Market Cap$125.07M
    Enterprise Value$115.47M
    Latest price (Nov 17, 2026)$6.94

    Key Dates

    The next earnings report is expected on Mar 3, 2027, covering the quarter ending Dec 31, 2026.

    Next Earnings DateMar 3, 2027 (expected)
    Last Earnings DateNov 11, 2026
    Fiscal Year EndDecember

    Share Statistics

    The share count rose 0.43% in the quarter ended Sep 30, 2026 and grew 1.47% a year over 2 years.

    Shares Outstanding18.87M
    Shares Change (YoY)+1.56%
    Shares Change (QoQ)+0.43%
    Share Count Growth (2Y CAGR)+1.47%

    Valuation Ratios

    Sales and book value multiples are 1.4x and 1.0x. Its year-end P/E ranged from 12.9x to 173.1x from 2018 to 2025.

    P/E Ratio7.5x
    Forward P/E7.6x
    P/S Ratio1.4x
    Forward P/S1.4x
    P/B Ratio1.0x
    P/TBV Ratio5.2x
    P/FCF Ratio6.6x
    P/OCF Ratio6.3x
    PEG Ratio0.6

    Valuation history and multiples

    Enterprise Valuation

    Counting debt and cash, the company is valued at 7.2x EBITDA and 6.2x free cash flow.

    EV / Earnings23.0x
    EV / Sales1.2x
    EV / EBITDA7.2x
    EV / EBIT9.9x
    EV / FCF6.2x

    Price Statistics

    The stock is down 54.28% over 52 weeks and trades 17.28% below its 50-day average.

    Beta (1Y)2.04
    52-Week Change-54.28%
    1-Month Change-20.59%
    3-Month Change-13.36%
    6-Month Change+43.69%
    5-Year Change-90.36%
    10-Year Change+870.83%
    Total Return (1Y)-54.28%
    Total Return (3Y CAGR)-11.07%
    Total Return (5Y CAGR)-37.36%
    Return vs SPY (1Y)-62.41%
    Max Drawdown (1Y)-70.50%
    Max Drawdown (3Y)-79.06%
    Sharpe Ratio (1Y)-0.99
    Correlation with SPY (1Y)0.39
    50-Day Average$8.39
    200-Day Average$7.12
    52-Week Range$4.54 to $15.59
    RSI (14 Days)33.6
    Average Volume (20 Days)256.67K

    The 5 and 10 year changes compare month-end closes, adjusted for splits, through Oct 2026.

    Price chart

    Financial Position

    Current assets cover 5.06x current liabilities, and total debt is 0.10x shareholder equity.

    Current Ratio5.06x
    Quick Ratio5.06x
    Debt / Equity0.10x
    Debt / EBITDA0.75x
    Debt / FCF0.65x
    Interest Coverage3.16x

    Returns and Efficiency

    Return on invested capital is 5.18% over the last 12 months, against a 5-year average of -5.77%.

    Return on Equity (ROE)3.75%
    Return on Assets (ROA)3.10%
    Return on Invested Capital (ROIC)5.18%
    Return on Capital Employed (ROCE)7.71%
    ROE (5Y Average)-7.17%
    ROA (5Y Average)-5.33%
    ROIC (5Y Average)-5.77%
    Asset Turnover0.57x
    Receivables Turnover3.77x

    Taxes

    Income tax took 39.54% of pretax income over the last 12 months.

    Income Tax (TTM)$3.28M
    Effective Tax Rate39.54%

    Scores

    OPRX has an Altman Z-Score of 3.23, in the safe zone above 2.99, and a Piotroski F-Score of 8 of 9, in the strong band of 8 or 9.

    Altman Z-Score3.23
    Altman Z ZoneSafe
    Piotroski F-Score8 of 9
    Piotroski StrengthStrong

    Income Statement

    Revenue was $94.20M over the last 12 months.

    Revenue$94.20M
    Revenue Growth (YoY)-13.98%
    Gross Profit$70.97M
    Operating Income$11.55M
    Pretax Income$8.30M
    Net Income$5.02M
    EBITDA$16.96M
    EBIT$11.69M
    Reported EPS (TTM)$0.92

    Trailing 12 months through Sep 30, 2026.

    Full financial statements

    Balance Sheet

    Shareholder equity funds 82.60% of the $162.09M in total assets.

    Cash and Equivalents$22.32M
    Total Debt$12.73M
    Net Cash$9.60M
    Net Cash Per Share$0.51
    Working Capital$42.55M
    Shareholder Equity$133.88M
    Book Value Per Share$7.10
    Tangible Book Value$25.34M
    Tangible Book Per Share$1.34
    Total Assets$162.09M
    Total Liabilities$28.21M

    Balance sheet as of Sep 30, 2026.

    Full balance sheet

    Cash Flow

    After $274.00K of capital spending, operating cash flow left $19.69M of free cash flow.

    Operating Cash Flow$19.97M
    Capital Expenditures$274.00K
    Free Cash Flow$19.69M
    FCF Per Share$1.05
    Depreciation and Amortization$5.26M

    Trailing 12 months through Sep 30, 2026.

    Full cash flow statement

    Margins

    The operating margin is 12.26%, against a 5-year average of -12.04%.

    Gross Margin75.33%
    Operating Margin12.26%
    Pretax Margin8.81%
    Net Margin5.33%
    EBITDA Margin18.00%
    EBIT Margin12.41%
    FCF Margin20.91%
    Gross Margin (5Y Average)62.45%
    Operating Margin (5Y Average)-12.04%
    Net Margin (5Y Average)-11.88%

    Growth

    Revenue grew 20.56% a year over 3 years, and EPS 39.49% a year.

    Revenue Growth (3Y CAGR)+20.56%
    Revenue Growth (5Y CAGR)+20.37%
    EPS Growth (3Y CAGR)+39.49%
    EPS Growth (5Y CAGR)+39.47%
    FCF Growth (3Y CAGR)+21.45%
    Book Value Per Share Growth (2Y CAGR)-2.54%
    Tangible Book Per Share Growth (2Y CAGR)+5.50%

    Revenue and profit by year

    Dividends and Yields

    OPRX does not pay a dividend. Its free cash flow yield is 15.04%.

    Earnings Yield13.33%
    FCF Yield15.04%
    Shareholder Yield0.00%

    Peer Position

    Against 5 similar companies, OPRX has the 5th highest P/E.

    P/E Ratio7.5x vs 13.0x median
    P/S Ratio1.4x vs 1.5x median
    ROIC5.18% vs 7.67% median
    Revenue Growth (Trailing 4 Quarters, YoY)-13.98% vs +2.08% median

    Competitors compared

    Analyst Forecast

    Consensus estimates put revenue growth at -5.46% and EPS growth at 5.23% a year over the next 2 fiscal years.

    Revenue Growth Forecast (2Y CAGR)-5.46%
    EPS Growth Forecast (2Y CAGR)+5.23%

    Analyst estimates by year

    Price Target

    Analyst price targets are part of paid GNG plans. See plans

    GNG Valuation

    GNG viewUndervalued

    GNG fair value is part of GNG Pro. See plans

    Frequently Asked Questions About OPRX

    What is OPRX's market cap?

    OPTIMIZERx has a market cap of $125.07M. Its enterprise value, which adds debt and subtracts cash, is $115.47M.

    What is OPRX's P/E ratio?

    OPTIMIZERx has a trailing P/E ratio of 7.5x and a forward P/E of 7.6x.

    How many shares of OPRX are outstanding?

    OPTIMIZERx has 18.87M shares outstanding. The count is up 1.56% from a year earlier.

    Does OPRX pay a dividend?

    No. OPTIMIZERx does not pay a dividend.

    How much debt does OPRX have?

    OPTIMIZERx has $12.73M of total debt and $22.32M of cash and equivalents, a net cash position of $9.60M.